TheEdgeResearch
Home / Stocks / BCTX

BriaCell Therapeutics Corp. (BCTX)

NASDAQ Healthcare Biotechnology
$3.06 ▼ -3.16%
Market Cap
$26.7M
Sector
Healthcare
Industry
Biotechnology
Beta
1.52
52-Wk Range
2.6-13.09
CEO
William V. Williams
Country
CA
Currency
USD

BriaCell Therapeutics Corp. operates in the Biotechnology industry of the Healthcare sector, headquartered in West Vancouver, BC, CA. The stock last traded at $3.06, down 3.16% on the session, giving a market capitalisation of $26.7M. On trailing twelve-month figures it carries a trailing P/E of -0.33, a net margin of 0.0%. Its beta of 1.52 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.33
Price / Sales
0.00
Price / Book
1.63
EV / EBITDA
-0.48
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
2.76
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
31
IPO date
2012-03-14
Headquarters
West Vancouver, BC, CA
About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. is a biotechnology company focused on immuno-oncology, dedicated to developing innovative immune-based therapies for cancer treatment. Its primary therapeutic candidate, Bria-IMT, is a whole-cell cancer vaccine currently undergoing Phase I/IIa clinical trials, where it is being evaluated in combination with the investigational immunotherapy retifanlimab. The company's pipeline also includes Bria-OTS, an accessible, personalized immunotherapy for advanced breast cancer, and BriaDx, a diagnostic test designed to determine patients' HLA types. BriaCell has established a non-exclusive clinical trial collaboration with Incyte Corporation to assess the effects of combining novel therapeutic candidates. Additionally, it holds a cooperative research and development agreement with the National Cancer Institute for preclinical studies to advance and test Bria-OTS cellular immunotherapy as a cancer treatment. The company's headquarters are situated in West Vancouver, Canada.

Comparable companies

BriaCell Therapeutics Corp. is most often compared with the following Healthcare names:

ALLRASBPCRISCTXRENTOHOTHLPTXMBRXPALIPCSA
More research on BCTX
BCTX technical analysis BCTX TheEdge Score Compare against peers
Open full interactive analysis & DCF →